ABSORB EXTEND Clinical Investigation
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 812 participants.
Also called NCT01023789
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 812 participants
- Sponsor
- Registry
-
NCT01023789 -
ACTRN12610000131055
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Argentina, Australia, Austria, Belgium, Brazil, Canada, China, Denmark, France, Germany, India, Israel, Italy, Japan, Malaysia, Netherlands, New Zealand, Poland, Singapore, South Africa, Spain, Sweden, Switzerland, Taiwan, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT01023789. Allocation not applicable; no masking; primary purpose treatment. Start 2010-01 (registry gives no type); primary completion 2016-10 (actual). Results posted on 2017-12-18.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- ABSORB EXTEND Clinical Investigation
- Acronym
- ABSORB EXTEND
- Condition
- Myocardial Ischemia
- Condition
- Coronary Artery Stenosis
- Condition
- Coronary Disease
- Condition
- Coronary Artery Disease
- Condition
- Coronary Restenosis
- Condition
- Cardiovascular Disease
- Intervention (Device)
- ABSORB BVS
- Lead sponsor
- Abbott Medical Devices
Record details
- Record id
cardio:ct-nct01023789- Content hash
264562cb002ea631fdabbbf096d34a1ba69dfd7e82f2b6dd8bcb2b1078985ad9